Gilles Naeije1,2, Antonin Rovai1, Massimo Pandolfo2,3, Xavier De Tiège1. 1. Laboratoire de Cartographie Fonctionnelle du Cerveau, ULB Neuroscience Institute Université libre de Bruxelles (ULB) Brussels Belgium. 2. Department of Neurology, CUB Hôpital Erasme Université libre de Bruxelles (ULB) Brussels Belgium. 3. Laboratoire de Neurologie Expérimentale, ULB Neuroscience Institute Université libre de Bruxelles (ULB) Brussels Belgium.
Abstract
BACKGROUND: Loss of hand dexterity has a profound impact on disability in patients with cerebellar, pyramidal, or extrapyramidal diseases. Analysis of multiple finger tapping (FT) parameters can contribute to identify the underlying physiopathology, while providing a quantitative clinical assessment tool, particularly in patients not reliably evaluated using clinical rating scales. Here, we used an automated method of FT analysis in Friedreich ataxia (FRDA) to disentangle cerebellar (prominent FT rate variability), extrapyramidal (FT progressive amplitude reduction without slowing of tapping rate), and pyramidal (progressive decrease of FT rate and amplitude) contribution to upper limb loss of dexterity. FT parameters were then related to FRDA clinical parameters and upper limbs motor evoked potential (MEPs). METHODS: Twenty-four FRDA patients and matched healthy subjects performed FT with the dominant hand for 90 seconds. FT rate, FT rate variability, FT amplitude, and linear regressions of FT movement parameters were automatically computed. Eleven patients underwent MEPs, measured at the first dorsal interosseous of the dominant hand to determine central motor conduction time (CMCT). RESULTS: FRDA patients had slower and more regular FT rate than controls. Eleven FRDA patients showed FT rate slowing. Those patients had longer disease duration and higher Scale for the Assessment and Rating of Ataxia (SARA) scores. Seven patients with FT rate slowing had MEP and all displayed prolonged CMCT, whereas the 4 other patients with constant FT rate had normal CMCT. CONCLUSION: This study provides evidence for a prominent involvement of pyramidal dysfunction in upper limb dexterity loss as well as a potential outcome measure for clinical studies in FRDA.
BACKGROUND: Loss of hand dexterity has a profound impact on disability in patients with cerebellar, pyramidal, or extrapyramidal diseases. Analysis of multiple finger tapping (FT) parameters can contribute to identify the underlying physiopathology, while providing a quantitative clinical assessment tool, particularly in patients not reliably evaluated using clinical rating scales. Here, we used an automated method of FT analysis in Friedreich ataxia (FRDA) to disentangle cerebellar (prominent FT rate variability), extrapyramidal (FT progressive amplitude reduction without slowing of tapping rate), and pyramidal (progressive decrease of FT rate and amplitude) contribution to upper limb loss of dexterity. FT parameters were then related to FRDA clinical parameters and upper limbs motor evoked potential (MEPs). METHODS: Twenty-four FRDA patients and matched healthy subjects performed FT with the dominant hand for 90 seconds. FT rate, FT rate variability, FT amplitude, and linear regressions of FT movement parameters were automatically computed. Eleven patients underwent MEPs, measured at the first dorsal interosseous of the dominant hand to determine central motor conduction time (CMCT). RESULTS: FRDA patients had slower and more regular FT rate than controls. Eleven FRDA patients showed FT rate slowing. Those patients had longer disease duration and higher Scale for the Assessment and Rating of Ataxia (SARA) scores. Seven patients with FT rate slowing had MEP and all displayed prolonged CMCT, whereas the 4 other patients with constant FT rate had normal CMCT. CONCLUSION: This study provides evidence for a prominent involvement of pyramidal dysfunction in upper limb dexterity loss as well as a potential outcome measure for clinical studies in FRDA.
Authors: H Akhlaghi; L Corben; N Georgiou-Karistianis; J Bradshaw; M B Delatycki; E Storey; G F Egan Journal: Brain Res Date: 2012-07-03 Impact factor: 3.252
Authors: Andrea Ginestroni; Stefano Diciotti; Paolo Cecchi; Ilaria Pesaresi; Carlo Tessa; Marco Giannelli; Riccardo Della Nave; Elena Salvatore; Fabrizio Salvi; Maria Teresa Dotti; Silvia Piacentini; Andrea Soricelli; Mirco Cosottini; Nicola De Stefano; Mario Mascalchi Journal: Hum Brain Mapp Date: 2011-06-14 Impact factor: 5.038
Authors: M Lamartine Monteiro; M Bourguignon; M Sjogard; G Remiche; S Goldman; X De Tiège; G Naeije Journal: Clin Neurophysiol Date: 2020-03-31 Impact factor: 3.708
Authors: Ian H Harding; Parnesh Raniga; Martin B Delatycki; Monique R Stagnitti; Louise A Corben; Elsdon Storey; Nellie Georgiou-Karistianis; Gary F Egan Journal: J Neurol Neurosurg Psychiatry Date: 2016-03-24 Impact factor: 10.154
Authors: T Schmitz-Hübsch; S Tezenas du Montcel; L Baliko; J Berciano; S Boesch; C Depondt; P Giunti; C Globas; J Infante; J-S Kang; B Kremer; C Mariotti; B Melegh; M Pandolfo; M Rakowicz; P Ribai; R Rola; L Schöls; S Szymanski; B P van de Warrenburg; A Dürr; T Klockgether; Roberto Fancellu Journal: Neurology Date: 2006-06-13 Impact factor: 9.910
Authors: G Naeije; M Bourguignon; V Wens; B Marty; S Goldman; R Hari; V Jousmäki; M Pandolfo; X De Tiège Journal: Clin Neurophysiol Date: 2019-12-02 Impact factor: 3.708
Authors: Adonay S Nunes; Nataliia Kozhemiako; Christopher D Stephen; Jeremy D Schmahmann; Sheraz Khan; Anoopum S Gupta Journal: Front Neurol Date: 2022-02-28 Impact factor: 4.003